The Elevated research standard
Research you
can inspect.
Every monograph is reviewed as four separate questions: what the reference substance is, what the source studied, what the evidence cannot establish, and what U.S. authorities currently say.
Elevated Pharma / Free research tool
Peptide research checklist.
Five questions to keep beside a research reference or analytical report. Use them to identify what is documented and what still needs an answer.
No account or upload needed. Checkmarks stay on this page and are not sent to our team.
Review the five questions above.
Published by Elevated Pharma · Documentation guidance reviewed October 7, 2026. Sources describe their own methods and records, not Elevated Pharma batches or customer results.
GenScript: analytical reportsBachem: peptide documentationelevatedpharma.org/methodology#research-checklist
Peptide documentation guide
How to read a peptide certificate of analysis.
A certificate of analysis (COA) reports analytical results for a specified batch or sample. Start with the lot identifier, then read the methods and results together. A headline purity percentage is only one part of the record.
Documentation guide updated October 7, 2026. The technical sources below explain their own analytical methods; they do not verify an Elevated Pharma material.
Compare the product name, sequence or chemical form, product identifier and lot number with the material under review. Bachem’s analytical documentation FAQ describes batch-specific records and the fields reported for peptides.
High-performance liquid chromatography separates components. Inspect the chromatogram, detection wavelength, column, gradient and peak table alongside the reported area percentage. These details affect what the analysis can resolve. See GenScript’s HPLC report guide.
Mass spectrometry measures mass-to-charge signals used to assess molecular mass. Compare the reported result with the expected mass and stated method. This addresses a different question from chromatographic purity. GenScript explains the MS report.
HPLC purity and net peptide content are different measures. Gross sample weight can include counterions and residual water; a high chromatographic percentage does not mean every milligram is the desired peptide. Bachem explains purity, gross weight and net peptide content.
Three results. Three different questions.
Peptide purity vs. content: what is the difference?
HPLC purity describes a chromatographic result. Peptide content describes how much of the sample is peptide. A mass spectrum helps assess molecular mass. Read them together; one result cannot fill in another result that is missing.
| Reported result | How to read it |
|---|---|
| HPLC purity | Look for: the target peak’s area relative to the integrated peaks, with the chromatogram and method. Separate from: net peptide content and gross sample weight. |
| Mass spectrometry | Look for: measured molecular mass compared with the expected mass, with the spectrum and method. Separate from: the amount of peptide in the container. |
| Peptide content | Look for: the peptide portion of the sample, distinct from non-peptide components such as water and counterions. Separate from: chromatographic purity. Check the content method and reporting basis. |
Sources: GenScript’s guide to HPLC and MS reports; CPC Scientific’s explanations of purity, content and gross versus net weight. This comparison was reviewed October 9, 2026.
Source hierarchy
The source controls the claim.
A source is cited only for the fact it can support. A database record, a cell experiment, an animal model, and a human trial are not interchangeable evidence.
FDA labels, DailyMed, FDA substance records, and current FDA reviews control approval, identity, and U.S. regulatory context.
ClinicalTrials.gov controls registered study status. Registration does not establish a result or authorize another material.
PubMed-indexed papers establish only the substance, model, method, and findings actually reported by the authors.
PubChem supports reference identifiers, formulas, and molecular mass. It does not verify a supplier, package, or lot.
Evidence labels
Stage is visible on every record.
The label describes the strongest source represented in the monograph. It is not a quality grade or a recommendation.
An approved named drug product exists. Approval does not transfer to another source or material.
A human investigational program is registered or published; the library makes no approval claim.
Human research exists, but its scope and limitations remain explicit.
The represented work is cellular, analytical, or animal research.
The supplied name does not resolve to one unambiguous molecular identity.
A combination is indexed by its parts; no mixture-level conclusion is assigned.
Correction rule
Uncertainty stays visible.
Conflicting names, salt forms, counterions, sequences, and mixture definitions remain unresolved until exact records close the gap. Monographs are revised when a controlling source changes.
Product documentation
A location is not a supply chain.
U.S.-based describes our business location. It does not establish where a material was synthesized, tested or packaged. These are separate claims that require exact product and supplier records.
A published study identifies its own test material. A certificate of analysis describes the sample and methods on that report. Neither automatically verifies a different supplier’s material or every lot. For a specific reference or document question, send a research inquiry.